When is ethics approval unethical?

Bioethics is an area of deep personal interest to me, and it is something that has challenged me many times in my entrepreneurial career. There are always opportunities to cut corners, to be “selective” with information, to be biased in decision making. Biomedical research and product development is tough because the dollars at stake are…

Dolly the sheep died young

In response to my question on yesterday’s post about Orthocell, several people forwarded me the link to a stock advert from a “publishing company” called Port Phillip Publishing. Just in case the link goes away, you can access the content here. The piece is called the “Body Hackers”. Sounds a bit more like an abattoir than a regen…

Orthosmell

Orthocell (ASX : OCC) has had two ASX “slaps” in the last month, to which the company pleaded “Schultz“. The first involved a bout of trading around the 6th of July. The second, a more detailed price query follow-up including some concerns in relation to activity on/around the 14th of July. Today we saw another…

The Incest of ASX Biopharma

It’s pretty hard to beat the Brits when it comes to situational comedy. As a dual-Australian/Canadian national educated in the UK, I suppose I have an intrinsic affinity for that dry, offhand style of humour. A few years ago, I stumbled across a brilliant comedy skit that visually captures precisely the fundamental reason why ASX biopharma is…

The Australian Schultz Exchange

To be honest with you, I am not a big fan of over-regulation, I like things simple and I hate “Big Government”. But I also believe that something as important as our public markets need some boundary conditions. In my mind, the ASX has demonstrated in the past few weeks that it is not only…

ASX Price Queries – give me a break…

A few hours ago, Orthocell received an ASX Price Query in reaction to an almost 20% bump in share price today, despite no new information to the market since May when an R&D tax credit was announced (yawn). I think it was summed up with almost nonchalant indifference by a punter on HotCopper: Does anyone…

Orthocell : Love Me Tendon, Love Me True…

In a previous post, I discussed the potential risk to the “quackery” end of Australia’s stem cell medicine industry if the TGA ever had a change of heart about how autologous (“from self”) cell therapies are regulated. At one end of the spectrum we have proven cell therapies that have been saving lives for a long…